Page 55 - 74_04
P. 55
VOL. 74 (4) PROSTANOIDS ACTIONS IN CARDIOVASCULAR...
(34) SAMUELSSON, B.; MORGENSTERN, R. AND JAKOBSSON, P. J. (2007) Membrane
prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59:
207-224.
(35) MURAKAMI, M.; NAKASHIMA, K.; KAMEI, D.; MASUDA, S.; ISHIKAWA, Y.; ISHII,
T.; OHMIYA, Y.; WATANABE, K. AND KUDO, I. (2003) Cellular prostaglandin
E2 production by membrane-bound prostaglandin E synthase-2 via both
cyclooxygenases-1 and -2. J. Biol. Chem. 278: 37937-37947.
(36) KANAOKA, Y. AND URADE, Y. (2003) Hematopoietic prostaglandin D synthase.
Prostaglandins Leukot Essent Fatty Acids. 69: 163-167.
(37) URADE, Y. AND HAYAISHI, O. (2000) Biochemical, structural, genetic,
physiological, and pathophysiological features of lipocalin-type prostaglandin
D synthase. Biochim. Biophys. Acta. 1482: 259-271.
(38) SCHER, J. U. AND PILLINGER, M. H. (2005) 15d-PGJ2: the anti-inflammatory
prostaglandin? Clin. Immunol. 114: 100-109.
(39) WATANABE, K. (2002) Prostaglandin F synthase. Prostaglandins Other Lipid
Mediat. 68-69: 401-407.
(40) WU, K. K. AND LIOU, J. Y. (2005) Cellular and molecular biology of
prostacyclin synthase. Biochem. Biophys. Res. Commun. 338: 45-52.
(41) WANG, L. H. AND KULMACZ, R. J. (2002) Thromboxane synthase: structure and
function of protein and gene. Prostaglandins Other Lipid Mediat. 68-69: 409-
422.
(42) HATA, A. N. AND BREYER, R. M. (2004) Pharmacology and signaling of
prostaglandin receptors: multiple roles in inflammation and immune
modulation. Pharmacol. Ther. 103: 147-166.
(43) KABASHIMA, K. AND NARUMIYA, S. (2003) The DP receptor, allergic
inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids. 69: 187-
194.
(44) TSUBOI, K.; SUGIMOTO, Y. AND ICHIKAWA, A. (2002) Prostanoid receptor
subtypes. Prostaglandins Other Lipid Mediat. 68-69: 535-556.
(45) SMYTH, E. M. AND FITZGERALD, G. A. (2002) Human prostacyclin receptor.
Vitam. Horm. 65: 149-165.
(46) STRAUS, D. S. AND GLASS, C. K. (2001) Cyclopentenone prostaglandins: new
insights on biological activities and cellular targets. Med. Res. Rev. 21: 185-
210.
(47) BERGER, J. AND MOLLER, D. E. (2002) The mechanisms of action of PPARs.
Annu. Rev. Med. 53: 409-435.
(48) IDE, T.; EGAN, K.; BELL-PARIKH, L. C. AND FITZGERALD, G. A. (2003)
Activation of nuclear receptors by prostaglandins. Thromb. Res. 110: 311-
315.
(49) GRAU, R.; INIGUEZ, M. A. AND FRESNO, M. (2004) Inhibition of activator
protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2
expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma
19